156 related articles for article (PubMed ID: 9699531)
1. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia.
Suzuki K; Ogura T; Yokose T; Nagai K; Mukai K; Kodama T; Nishiwaki Y; Esumi H
Int J Cancer; 1998 Aug; 79(4):384-9. PubMed ID: 9699531
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.
Takamochi K; Ogura T; Suzuki K; Kawasaki H; Kurashima Y; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Esumi H
Am J Pathol; 2001 Nov; 159(5):1941-8. PubMed ID: 11696455
[TBL] [Abstract][Full Text] [Related]
3. A case of double primary adenocarcinoma of the lung with multiple atypical adenomatous hyperplasia.
Anami Y; Matsuno Y; Yamada T; Takeuchi T; Nakayama H; Hirohashi S; Noguchi M
Pathol Int; 1998 Aug; 48(8):634-40. PubMed ID: 9736412
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the TSC1 gene in adenocarcinoma of the lung.
Takamochi K; Ogura T; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Suzuki K; Esumi H
Lung Cancer; 2004 Dec; 46(3):271-81. PubMed ID: 15541811
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in tuberous sclerosis hamartomas.
Sepp T; Yates JR; Green AJ
J Med Genet; 1996 Nov; 33(11):962-4. PubMed ID: 8950679
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
8. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
Wolf HK; Normann S; Green AJ; von Bakel I; Blümcke I; Pietsch T; Wiestler OD; von Deimling A
Acta Neuropathol; 1997 Jan; 93(1):93-6. PubMed ID: 9006662
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.
Henske EP; Scheithauer BW; Short MP; Wollmann R; Nahmias J; Hornigold N; van Slegtenhorst M; Welsh CT; Kwiatkowski DJ
Am J Hum Genet; 1996 Aug; 59(2):400-6. PubMed ID: 8755927
[TBL] [Abstract][Full Text] [Related]
11. [Fine deletion mapping on chromosome 8p21 - 8p22 in adenocarcinoma of lung].
Shao S; Sun W; Zhang J; An Q; Xiao T; Yang P; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):740-2. PubMed ID: 12126542
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
[TBL] [Abstract][Full Text] [Related]
13. Different pattern of loss of heterozygosity among endocervical-type adenocarcinoma, endometrioid-type adenocarcinoma and adenoma malignum of the uterine cervix.
Tsuda H; Takarabe T; Okada S; Uchida H; Kasamatsu T; Yamada T; Tsunematsu R; Ohmi K; Hirohashi S
Int J Cancer; 2002 Apr; 98(5):713-7. PubMed ID: 11920640
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
Froudarakis ME; Sourvinos G; Fournel P; Bouros D; Vergnon JM; Spandidos DA; Siafakas NM
Chest; 1998 Apr; 113(4):1091-4. PubMed ID: 9554652
[TBL] [Abstract][Full Text] [Related]
15. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor.
Green AJ; Johnson PH; Yates JR
Hum Mol Genet; 1994 Oct; 3(10):1833-4. PubMed ID: 7849709
[TBL] [Abstract][Full Text] [Related]
16. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung.
Yamasaki M; Takeshima Y; Fujii S; Matsuura M; Tagawa K; Inai K
Pathol Int; 2000 Nov; 50(11):891-6. PubMed ID: 11107065
[TBL] [Abstract][Full Text] [Related]
17. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
[TBL] [Abstract][Full Text] [Related]
18. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
19. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.
Yamasaki M; Takeshima Y; Fujii S; Kitaguchi S; Matsuura M; Tagawa K; Inai K
Pathol Int; 2000 Oct; 50(10):778-85. PubMed ID: 11107049
[TBL] [Abstract][Full Text] [Related]
20. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
Dacic S; Finkelstein SD; Yousem SA
Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
